Come up with a name for your new list and we'll add to it:
Achaogen raised a round of funding on , . Investors include
Gold Hill Capital.
Achaogen specializes in the discovery and development of small molecules to treat infections caused by bacterial infection, and by antibiotic-resistant strains in particular. Achaogen focuses on high …